JNJ

Johnson & Johnson
D

JNJ

Arincen70/100B

Johnson & Johnson operating income 1985–2026

Johnson & Johnson's operating income in Q3 FY2026, the three months to 27 September 2026, was 6.37B USD, down 10.3% on the same quarter a year before. Johnson & Johnson's operating income over the last twelve months was 25.53B USD, up 6.2% on the twelve months before. In fiscal year 2025 it was 25.60B USD, up 15.6% on the year before.

Last updated 7 Nov 2026 · Next report 26 Jan 2027

Operating income

Operating income · +3.4% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM27 Sept 202625.53B+6.15%25.70%68.35B68.81%30.81B
FY202528 Dec 202525.60B+15.56%27.17%63.94B67.88%41.06B
FY202429 Dec 202422.15B-5.38%24.94%61.35B69.07%24.78B
FY202331 Dec 202323.41B+11.40%27.49%58.61B68.82%23.32B
FY20221 Jan 202321.01B+0.33%26.27%55.39B69.25%26.61B
FY20212 Jan 202220.94B+6.13%26.60%55.34B70.28%26.75B
FY20203 Jan 202119.73B-5.90%23.89%54.16B65.58%23.93B
FY201931 Dec 201920.97B-0.97%25.55%54.50B66.42%24.66B
FY201831 Dec 201821.18B+12.05%25.96%54.49B66.79%25.93B
FY201731 Dec 201718.90B-9.54%24.72%51.01B66.72%24.25B
FY201631 Dec 201620.89B+14.23%29.06%50.10B69.69%24.28B
FY201531 Dec 201518.29B-13.47%26.10%48.54B69.27%23.49B
FY201431 Dec 201421.14B+11.50%28.44%51.59B69.40%24.99B
FY201331 Dec 201318.96B+11.30%26.58%48.97B68.67%20.06B
FY201231 Dec 201217.03B+5.44%25.34%45.57B67.78%17.97B
FY201131 Dec 201116.15B-2.26%24.84%44.67B68.69%16.09B
FY201031 Dec 201016.53B-0.82%26.84%42.80B69.49%20.34B
FY200931 Dec 200916.66B+3.06%26.92%43.45B70.20%18.98B
FY200831 Dec 200816.17B+6.28%25.36%45.24B70.96%20.20B
FY200731 Dec 200715.21B+10.97%24.90%43.34B70.95%16.36B
FY200631 Dec 200613.71B+6.84%25.71%38.27B71.76%15.89B
FY200531 Dec 200512.83B+3.84%25.40%36.50B72.27%14.92B
FY200431 Dec 200412.36B+13.66%26.10%33.87B71.54%14.48B
FY200331 Dec 200310.87B+12.33%25.97%29.69B70.91%12.74B
FY200231 Dec 20029.68B+22.74%26.66%25.85B71.22%11.34B
FY200131 Dec 20017.89B+19.20%24.40%22.74B70.35%9.49B
FY200031 Dec 20006.62B+10.53%22.68%20.22B69.30%8.21B
FY199931 Dec 19995.99B+19.03%21.37%19.51B69.66%7.50B
FY199831 Dec 19985.03B+8.78%20.95%17.68B73.67%6.31B
FY199731 Dec 19974.62B+7.41%20.43%16.54B73.11%5.69B
FY199631 Dec 19964.30B+22.56%19.90%15.61B72.21%5.31B
FY199531 Dec 19953.51B+25.08%18.63%13.46B71.46%4.37B
FY199431 Dec 19942.81B+17.25%17.84%11.16B70.92%3.53B
FY199331 Dec 19932.39B+5.14%16.93%9.96B70.48%3.01B
FY199231 Dec 19922.28B+5.22%16.56%9.64B70.06%2.84B
FY199131 Dec 19912.16B+8.63%17.39%8.74B70.19%2.66B
FY199031 Dec 19901.99B+19.93%17.74%7.77B69.17%2.47B
FY198931 Dec 19891.66B+18.30%17.02%6.69B68.58%2.08B
FY198831 Dec 19881.40B+16.13%15.60%6.10B67.77%1.80B
FY198731 Dec 19871.21B+22.92%15.09%5.41B67.52%1.57B
FY198631 Dec 1986983.60M+17.10%14.05%4.65B66.37%1.26B
FY198531 Dec 1985840.00M—13.08%4.08B63.50%1.09B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Johnson & Johnson's operating income

Source: Financial Modeling PrepVerified against SEC filings